Movement Alert｜ASYMCHEM rises 3.2% in Regular Trading, earnings review nears as pharma shares strengthen

Market Focus

Oct 20

On October 20, ASYMCHEM rose 3.2% in Regular Trading, trading at HK$142.0, with turnover of HK$54.18 million.

The move coincided with the company’s approaching third-quarter earnings review on October 22 and a broader rally across pharmaceutical names, which lifted sentiment toward the CXO and innovative drug supply chain.

Company disclosures show the board is scheduled to consider and approve results for the nine months ended September 30 on October 22. Separately, a public fund third-quarter report showed that a healthcare-focused fund significantly increased its position in ASYMCHEM and raised it to its largest holding, reinforcing market attention on leading CXO names. On the same day, peers in the pharmaceuticals sector also advanced, including HANSOH PHARMA, ALEBUND-B, HENGRUI PHARMA, SBP GROUP and CSPC PHARMA.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1193362412"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1193362412\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1193362412?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-20 11:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193362412","market":"hk","top_or_hot":-1,"title":"Movement Alert｜ASYMCHEM rises 3.2% in Regular Trading, earnings review nears as pharma shares strengthen","media":"Market Focus","content":"<p><p>On October 20, ASYMCHEM rose 3.2% in Regular Trading, trading at HK$142.0, with turnover of HK$54.18 million.</p><p>The move coincided with the company’s approaching third-quarter earnings review on October 22 and a broader rally across pharmaceutical names, which lifted sentiment toward the CXO and innovative drug supply chain.</p><p>Company disclosures show the board is scheduled to consider and approve results for the nine months ended September 30 on October 22. Separately, a public fund third-quarter report showed that a healthcare-focused fund significantly increased its position in ASYMCHEM and raised it to its largest holding, reinforcing market attention on leading CXO names. On the same day, peers in the pharmaceuticals sector also advanced, including HANSOH PHARMA, ALEBUND-B, HENGRUI PHARMA, SBP GROUP and CSPC PHARMA.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜ASYMCHEM rises 3.2% in Regular Trading, earnings review nears as pharma shares strengthen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜ASYMCHEM rises 3.2% in Regular Trading, earnings review nears as pharma shares strengthen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-20 11:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 20, ASYMCHEM rose 3.2% in Regular Trading, trading at HK$142.0, with turnover of HK$54.18 million.</p><p>The move coincided with the company’s approaching third-quarter earnings review on October 22 and a broader rally across pharmaceutical names, which lifted sentiment toward the CXO and innovative drug supply chain.</p><p>Company disclosures show the board is scheduled to consider and approve results for the nine months ended September 30 on October 22. Separately, a public fund third-quarter report showed that a healthcare-focused fund significantly increased its position in ASYMCHEM and raised it to its largest holding, reinforcing market attention on leading CXO names. On the same day, peers in the pharmaceuticals sector also advanced, including HANSOH PHARMA, ALEBUND-B, HENGRUI PHARMA, SBP GROUP and CSPC PHARMA.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06821","symbol_name":"凯莱英","start_time":0,"source_url":"","article_id":"1193362412","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193362412","pubTimestamp":1792465757,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 20, ASYMCHEM rose 3.2% in Regular Trading, trading at HK$142.0, with turnover of HK$54.18 million.The move coincided with the company’s approaching third-quarter earnings review on October...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06821":"凯莱英"},"translate_title":"走势警报|凯莱英常规交易中上涨 3.2%，随着制药股走强，盈利审查临近","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06821":1},"content_text":"On October 20, ASYMCHEM rose 3.2% in Regular Trading, trading at HK$142.0, with turnover of HK$54.18 million.The move coincided with the company’s approaching third-quarter earnings review on October 22 and a broader rally across pharmaceutical names, which lifted sentiment toward the CXO and innovative drug supply chain.Company disclosures show the board is scheduled to consider and approve results for the nine months ended September 30 on October 22. Separately, a public fund third-quarter report showed that a healthcare-focused fund significantly increased its position in ASYMCHEM and raised it to its largest holding, reinforcing market attention on leading CXO names. On the same day, peers in the pharmaceuticals sector also advanced, including HANSOH PHARMA, ALEBUND-B, HENGRUI PHARMA, SBP GROUP and CSPC PHARMA.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}